Article Information
History
- August 28, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Talía Malagón, PhD1,3,*,
- Jean H.E. Yong, MASc2,
- Parker Tope, BSc1,
- Wilson H. Miller Jr., MD3,
- Eduardo L. Franco, DrPH1,3,
- for the McGill Task Force on the Impact of COVID-19 on Cancer Control and Care*
- 1Division of Cancer Epidemiology, Department of Oncology, McGill University, Montreal, Quebec, Canada
- 2Canadian Partnership Against Cancer, Toronto, Ontario, Canada
- 3Department of Oncology, McGill University, Montreal, Quebec, Canada
- ↵*Correspondence: Talía Malagón, Division of Cancer Epidemiology, McGill University, 5100 de Maisonneuve Blvd W, Suite 720, Montréal, QC H4A 3T2, CANADA, 1-514-398-5894, talia.malagon{at}mcgill.ca